Castleark Management LLC Cuts Stake in CME Group (NASDAQ:CME)

Castleark Management LLC lessened its stake in shares of CME Group (NASDAQ:CME) by 5.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 333,179 shares of the financial services provider’s stock after selling 18,045 shares during the period. CME Group comprises 1.5% of Castleark Management LLC’s investment portfolio, making the stock its 7th largest holding. Castleark Management LLC owned about 0.10% of CME Group worth $48,661,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CME. Jackson Square Partners LLC grew its stake in CME Group by 672.4% during the 4th quarter. Jackson Square Partners LLC now owns 2,773,705 shares of the financial services provider’s stock valued at $405,099,000 after acquiring an additional 2,414,593 shares in the last quarter. Capital International Investors grew its stake in CME Group by 11.4% during the 3rd quarter. Capital International Investors now owns 12,489,045 shares of the financial services provider’s stock valued at $1,694,514,000 after acquiring an additional 1,279,058 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its stake in CME Group by 53.2% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,201,333 shares of the financial services provider’s stock valued at $321,505,000 after acquiring an additional 764,129 shares in the last quarter. Macquarie Group Ltd. grew its stake in CME Group by 816.2% during the 4th quarter. Macquarie Group Ltd. now owns 745,939 shares of the financial services provider’s stock valued at $121,811,000 after acquiring an additional 664,523 shares in the last quarter. Finally, Atlantic Trust Group LLC grew its stake in CME Group by 1,943.2% during the 3rd quarter. Atlantic Trust Group LLC now owns 606,942 shares of the financial services provider’s stock valued at $82,349,000 after acquiring an additional 577,237 shares in the last quarter. Hedge funds and other institutional investors own 83.11% of the company’s stock.

In related news, CFO John W. Pietrowicz sold 7,500 shares of the business’s stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $151.50, for a total value of $1,136,250.00. Following the completion of the sale, the chief financial officer now directly owns 32,376 shares in the company, valued at approximately $4,904,964. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Hilda Harris Piell sold 3,299 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $163.52, for a total value of $539,452.48. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 40,699 shares of company stock valued at $6,266,062. Corporate insiders own 0.57% of the company’s stock.

Several research firms have weighed in on CME. ValuEngine cut CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 7th. Zacks Investment Research cut CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 6th. Bank of America lifted their target price on CME Group from $175.00 to $185.00 and gave the company a “buy” rating in a research note on Thursday, March 8th. BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a research note on Thursday, March 15th. Finally, Barclays lifted their target price on CME Group from $170.00 to $175.00 and gave the company an “overweight” rating in a research note on Friday, February 2nd. Three investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $163.69.

Shares of NASDAQ CME traded down $4.73 during trading hours on Friday, hitting $158.26. The stock had a trading volume of 1,313,788 shares, compared to its average volume of 2,112,036. The stock has a market cap of $55,479.36, a price-to-earnings ratio of 33.18, a PEG ratio of 2.25 and a beta of 0.56. CME Group has a 52 week low of $114.82 and a 52 week high of $171.71. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.03 and a current ratio of 1.03.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.12 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.10 by $0.02. CME Group had a return on equity of 7.68% and a net margin of 111.49%. The business had revenue of $900.00 million during the quarter, compared to analysts’ expectations of $886.85 million. During the same quarter in the previous year, the business posted $1.14 EPS. The firm’s quarterly revenue was down 1.4% compared to the same quarter last year. analysts predict that CME Group will post 6.89 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Monday, March 26th. Investors of record on Friday, March 9th were issued a $0.70 dividend. This is a positive change from CME Group’s previous quarterly dividend of $0.66. This represents a $2.80 annualized dividend and a yield of 1.77%. The ex-dividend date of this dividend was Thursday, March 8th. CME Group’s payout ratio is 58.70%.

ILLEGAL ACTIVITY WARNING: “Castleark Management LLC Cuts Stake in CME Group (NASDAQ:CME)” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/04/07/cme-group-inc-cme-stake-lowered-by-castleark-management-llc.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply